3D Cell Culture Market, 2015 - 2025

  • Lowest Price Guaranteed From USD 2,199

  • Published
    May 2015

  • Pages

  • View Count

Example Insights

An updated edition is available at the following link 

View 2nd edition

  1. With a highly extensive classification, we have identified close to 150 3D culture systems. Of the two broad categories of scaffold-based and scaffold-free systems, scaffold-based systems are more popular, representing 76% of the 3D culture systems.
  2. Cancer research is currently the most well established application area and accounts for 40% of the present 3D culture market. Drug and toxicity screening have also emerged quite popular with 35% of the current market share.
  3. Stem cells and regenerative medicine together capture a share of 25% in the current 3D culture market and would gradually gain focus as the market matures in the field of therapeutics.
  4. Owing to the large life science market, the US holds maximum share (over 50%) of the current 3D culture market; EU, considered to be an early adopter, occupies around 30% of the current market. With increasing popularity of 3D culture systems, regions such as Asia and other countries of the world are also likely to start adopting 3D culture systems more aggressively.
  5. We expect the 3D culture market to be multi-billion dollar market by 2025, representing a healthy annual growth rate of 28%. As a result of this transition, we anticipate 3D cultures to capture 35% of the overall cell culture market in the next 10 years.

Report Description

The concept of growing tissues outside their natural system in an artificially created microenvironment is known as tissue culturing. It is a common tool for developing model systems that are useful for studying the basic human molecular and cell biology metabolisms. Cell culturing was first initiated in flat plastic or glass dishes as 2D cell culturing. Since then, all the tissue engineering, stem cell, molecular biology work is being carried out on the widely popular petri dishes. However, there are several limitations associated with 2D cell culture that hamper the morphology, growth rate, cell function, viability and the overall behaviour of the cell as compared to the natural environment. As a result, 2D cell culture is not efficient for studying complex molecular metabolisms.

To carry out studies in vitro, cells have to be supplemented with an environment that is a close replica of the natural environment. This can be accomplished by using 3D cell cultures which are physiologically more relevant as compared to the 2D cell cultures. Cells in a 3D culture form natural cell to cell interactions and synthesize extracellular material as they do in in vivo. These cells exert forces on each other, moving and migrating as they do in natural environment. In addition, the interactions between them include gap junctions that facilitate exchange of ions, electrical currents and small molecules enhancing the signalling and communication between them. Such a close representation of the natural system in vitro gives insights about the behaviour of the cell when stimulated with a potential drug or a chemical.

Presently, there are several scaffold-based and scaffold-free 3D systems in the market that are widely being used for the purpose of research in a variety of application areas. Although 2D cultures are still more prominent, the encouraging results of 3D cultures have motivated researchers across the world to gradually transition to 3D cultures systems.


Scope of the Report

The ‘3D Cell Culture Market, 2015-2025’ report provides an extensive study on the marketed 3D cell culture systems and those under development. There are a number of 3D cell culture systems that are already commercially available. However, these systems are primarily being used in a variety of research applications; therapeutic applications are still being explored. In addition, there are several promising 3D culture systems which are currently being developed worldwide; the approach is likely to result in many commercial success stories in the foreseen future. The report covers various aspects, such as, key players in the industry, 3D culture products in various biomedical applications and upcoming opportunities for several stakeholders.

As pharmaceutical companies continue to expand their research programs in this area, one of the key objectives outlined for this report is to understand the current and future potential of the market. This is done by analysing current trends in the wider cell culture market and the specific parameters which are likely to influence evolution of 3D cultures during the same time period. In addition, we have provided our outlook on the sub-market evolution of 3D culture instruments, 3D culture related consumables, 3D culture services and other biomaterials. We have also reviewed, in detail, the likely contribution to be made by different applications areas such as cancer research, drug and toxicity screening, stem cell research and regenerative medicines. The report also provides a snapshot of the likely evolution of the market across key geographies (US, EU and Asia).

To address the uncertainties in the market, we have provided three market forecast scenarios for the time period 2015 - 2025. The conservative, base and optimistic scenarios represent three different tracks of industry evolution. Our opinions and insights, presented in this study, were influenced by the discussions that we conducted with experts in this area. All actual figures have been sourced and analysed from publicly available information and discussions with industry experts. The figures mentioned in this report are in USD, unless otherwise specified.


Chapter 2  provides an executive summary of the insights captured in our research. The summary offers a high level view on where the 3D culture market is headed in the mid to long term.

Chapter 3  provides a general introduction to the 3D culture systems. In this section, we have briefly discussed the different types of cell cultures, conventional methods of cell culturing and various application domains. The chapter outlines a comparative analysis of 2D versus 3D cultures, focussing on the need and the advantages of 3D culture systems.

Chapter 4  gives an overview of the classification of 3D culture systems. It highlights the different approaches under the two broad categories of scaffold-based and scaffold-free 3D culture systems. We have discussed, in detail, the underlying concept, advantages and disadvantages of each sub-category of the two aforementioned strategies.

Chapter 5  summarises the different techniques deployed to fabricate various 3D matrices. It talks about the principle, merits and demerits associated with these methods. It also covers the key takeaways of several research studies carried out using these matrices.

Chapter 6  provides a comprehensive list of 3D culture systems. The list includes information on the 3D culture types and their respective sub-categories. We have also mapped the geographical presence of 3D culture systems. In addition, the chapter talks about other companies which provide 3D related services and associated consumables.

Chapter 7  provides applications of 3D culture systems in the field of cancer research. In addition, the chapter provides a holistic view on the various 3D culture products that have a key role to play in this domain.

Chapter 8  highlights the applications of 3D cultures in drug and toxicity screening. It elaborates on the liver models that can be utilised in toxicity and drug screening studies. The chapter also provides details on the 3D culture systems that have been deployed for this application.

Chapter 9  provides an overview of the 3D culture systems in the field of stem cell research. It highlights the scope of 3D culture approach in embryoid body formation and organogenesis. The chapter enlists and provides details of the 3D culture systems that have been used for the purpose of stem cell research.

Chapter 10  presents the detailed forecast for the 3D culture market segmented by type of 3D components, type of 3D system, type of applications and key geographies. Due to the uncertain nature of the market, we have presented three different growth tracks outlined as conservative, base and optimistic scenarios.

Chapter 11  provides detailed company profiles of the leading players in the market. Each company profile includes information such as financial performance, product portfolio, recent collaborations and future outlook.

Chapter 12  summarises the overall report. In this chapter, we provide a recap of the key takeaways and our independent opinion based on the research and analysis described in previous chapters.

Chapter 13  is a collection of interview transcript(s) of the discussions which were held during the course of this study.

Chapter 14  is an appendix which provides tabulated data and numbers for all the figures provided in the report.

Chapter 15  is an appendix which provides the list of companies mentioned in the report

Table of Contents

1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
3.1. Chapter Overview
3.2. Classification of Cell Cultures
3.2.1. Primary Cell Cultures
3.2.2. Secondary Cell Cultures
3.2.3. Cell Lines
3.3. Morphology of Cells in Culture
3.4. Process for Obtaining Cell Culture
3.4.1. Isolating Cells From Tissues
3.4.2. Maintaining Cells in Culture
3.4.3. Plating Density and Sub-Culturing
3.4.4. Cryogenic Storage
3.4.5. Issue of Cross-Contamination
3.5. The Need of Cell Culturing
3.5.1. Model Systems
3.5.2. Drug Screening and Pharmacological Testing
3.5.3. Cancer Research and Drug Discovery
3.5.4. Virology
3.5.5. Genetic Engineering and Gene Therapy
3.6. Basic Requirements for Cell Culture
3.6.1. Cell Culture Facility And Safety
3.6.2. Avoiding Contamination
3.6.3. Cell Culture Health And Optimal Conditions
3.7. Transition From 2D To 3D Cell Culture
3.8. The Concept of 3D Cell Culture
3.8.1. What is Extra Cellular Matrix (ECM)?
3.8.2. In Vitro Cell Culture
3.9. Advantages and Limitations of 3D Cell Culture
4.1. 3D Culture Classification: An Overview
4.2. Scaffold-based 3D Cultures
4.2.1. Hydrogels Or ECM Analogs
4.2.2. Solid Scaffolds
4.2.3. Micropatterned Surfaces
4.2.4. Microfluidic Surfaces
4.2.5. Microcarriers
4.3. Scaffold-Free 3D Cultures
4.3.1. Attachment Resistant Cell Surfaces
4.3.2. Suspension Cultures
5.1. Chapter Overview
5.2. Methods for Fabricating Porous Scaffolds
5.2.1. Particulate Leaching
5.2.2. Solvent Casting
5.2.3. Emulsion Templating
5.2.4. Gas Foaming
5.2.5. Melt Molding
5.2.6. Microsphere Sintering
5.3. Methods for Fabricating Fibrous Scaffolds
5.3.1. Fiber Mesh
5.3.2. Fiber Bonding
5.3.3. Electro Spinning
5.3.4. Phase Separations
5.3.5. Self Assembly
5.4. Methods for Fabricating Hydrogels
5.4.1. Solvent Casting And Particulate Leaching
5.4.2. Gas Foaming
5.4.3. Freeze Drying
5.4.4. Co-Polymerisation / Crosslinking Methods
5.4.5. Microfluidics
5.5. Methods for Fabricating Custom Scaffolds / Rapid Prototyping / Solid Free-Form (SFF) Technique
5.5.1. Stereo-Lithography
5.5.2. 3D Printing And Organ Printing
5.5.3. Selective Laser Sintering (SLS)
5.5.4. Fused Deposition Modeling
5.5.5. Membrane Lamination
5.6. Methods for Fabricating Microspheres
5.6.1. Solvent Evaporation
5.6.2. Single and Double Emulsification Technique
5.6.3. Particle Aggregated Scaffold
5.7. Methods for Fabricating Native Scaffolds
5.7.1. Decellularisation
6.1. Chapter Overview
6.2. 3D Culture System Market Overview
6.3. Scaffold-Based Formats Make A Significant Contribution In The Market
6.3.1. 3D Culture Systems: Distribution By Type of Hydrogels/ECMs
6.3.2. 3D Culture Systems: Distribution By Type of Solid Scaffolds
6.4. 3D Culture Systems: Distribution of Scaffold-Free Systems
6.4.1. 3D Culture Systems: Distribution by Type of Suspension Cultures
6.4.2. 3D Culture Systems: Distribution of Attachment Resistant Culture Surfaces
6.5. 3D Culture System Manufacturers: Regional Outlook
6.6. Other 3D Culture Consumables
6.7. 3D Culture Services
7.1. Chapter Overview
7.2. Reasons to Adopt 3D Culture Systems in Cancer Research
7.3. Improving Cancer Drug Screening with 3D Culture System
7.4. 3D Culture Models Used in Oncology
7.4.1. AlgiMatrix, Life Technologies
7.4.2. Cell-Mate3D, BRTI Life Sciences
7.4.3. CELLSTAR Cell-Repellent Surface, Greiner Bio-One International
7.4.4. Elplasia Micro-Space Cell Cultures, Kuraray
7.4.5. Matrigel Matrix, Corning Life Sciences
7.4.6. OncoSpheres, CYTOO
7.4.7. PetakaG3 Cell Culture Devices/Bioreactors, Celartia
7.4.8. QGel, QGel Bio
7.4.9. RAFT System, TAP Biosystems
7.4.10. RealBio D4 Culture System, RealBio Technology
8.1. Chapter Overview
8.2. Drug Screening
8.3. Application of 3D Cultures In Toxicity Studies
8.3.1. Liver As A Key Driver for 3D Innovation
8.3.2. Liver Metabolism
8.3.3. Liver Toxicity: Important Aspect In Toxicology Studies
8.3.4. Liver In Vitro Models
8.4. 3D Cultures Systems Used in Toxicological Studies
8.4.1. 3D Aligned NanoFiber Solutions, Nanofiber Solutions
8.4.2. 3D InSight Human Pancreatic MicroIslets, InSphero
8.4.3. 3D InSight Liver Microtissues, Insphero
8.4.4. 3D Liver Prototissue System, MC2 Biotek
8.4.5. DataChip/MetaChip, Solidus Biosciences
8.4.6. Epiderm Tissue Model, MatTek
8.4.7. exVive3D Liver, Organovo
8.4.8. Gravity PLUS Hanging Drop System, Insphero
8.4.9. LiverChip, CN Bio Innovations Ltd (Formerly Zyoxel Ltd.)
8.4.10. Mimetas OrganoPlates, Mimetas
8.4.11. Multizyme Chip: Multiple Enzyme Chip, Solidus Biosciences
8.4.12. RegeneTOX , Regenemed
8.4.13. TeamChip, Solidus Biosciences
9.1. Chapter Overview
9.2. Potential of 3D Culture Systems in Stem Cell Differentiation
9.3. In Vitro 3D Microenvironment to Induce Embryoid Body Formation
9.4. Organogenesis from Stem Cells
9.5. 3D Culture Systems in Stem Cell Research
9.5.1. AlphaMAX3D ECM, AlphaGenix
9.5.2. Cultrex BME PathClear, Trevigen
9.5.3. Lipidure-COAT Plates, NOF Corporation
9.5.4. MaxGel Human ECM, Sigma Aldrich
9.5.5. Nunclon Sphera, Thermo Fisher Scientific
9.5.6. Perfecta3D Hanging Drop Plates, 3D Biomatrix
9.5.7. PGMatrix, PepGel
9.5.8. PrimeSurface Cell Culture Plate, Sumito Bakelite
9.5.9. StemFit 3D, Prodizen
10.1. Chapter Overview
10.2. Forecast Methodology
10.3. Overall 3D Culture Market, 2015- 2025
10.4. 3D Culture Market Forecast, 2015-2025: Distribution by Components
10.5. 3D Culture Market Forecast, 2015-2025: Geographical Analysis
10.6. 3D Culture Market Forecast, 2015-2025: Distribution by Application
10.7. 3D Culture Market Forecast, 2015-2025: Distribution by Type of 3D System
11.1. Chapter Overview
11.2. Corning Life Sciences
11.2.1. Company Overview
11.2.2. Financial Details
11.2.3. Product Portfolio
11.2.4. Collaborations
11.2.5. Future Outlook
11.3. Life Technologies
11.3.1. Company Overview
11.3.2. Financial Details
11.3.3. Product Portfolio
11.3.4. Future Outlook
11.4. Sigma Aldrich
11.4.1. Company Overview
11.4.2. Financial Details
11.4.3. Product Portfolio
11.4.4. Future Outlook
11.5. Insphero
11.5.1. Company Overview
11.5.2. Product Portfolio
11.5.3. Collaborations
11.5.4. Future Outlook
11.6. 3D Biotek
11.6.1. Company Overview
11.6.2. Product Portfolio
11.6.3. Collaborations
11.7. Reinnervate
11.7.1. Company Overview
11.7.2. Product Portfolio
11.7.3. Alvetex 3D Culture Scaffold
11.7.4. Collaborations
11.7.5. Future Outlook
11.8. Synthecon
11.8.1. Company Overview
11.8.2. Product Portfolio
11.8.3. Collaborations
11.8.4. Future Outlook
11.9. Neuromics
11.9.1. Company Overview
11.9.2. Product Portfolio
11.9.3. Collaborations
11.10. Cosmo Bio
11.10.1. Company overview
11.10.2. Financial Details
11.10.3. Product Portfolio
11.10.4. Future Outlook
12.1. 3D Cultures Rapidly Replacing 2D Systems
12.2. 3D Cultures Have Invaded A Myriad Of Applications
12.3. 3D Cultures Yet to Unveil Potential in Therapeutics
12.4. With High Adoption Rates, 3D Cultures Will Emerge As A Multi-Billion Dollar Market

List of Figures

Figure 3.1  Classifications of Cell Cultures
Figure 3.2  Various Methods of Cell Isolation from Tissues
Figure 3.3  Methods of Cryogenic Storage
Figure 3.4  Applications of Cell Culturing
Figure 3.5  Cell Culture: Bio-Safety Levels
Figure 3.6 Differences in 2D and 3D Cell Cultures
Figure 3.7  Key Components of the ECM
Figure 3.8  Factors Influencing the Choice of 3D Culture Systems
Figure 4.1  Classification of 3D Culture Systems
Figure 4.2 Natural Components of ECM
Figure 4.3 Advantages and Disadvantages of Hydrogels
Figure 6.1  3D Culture Systems: Distribution by Type of System
Figure 6.2  3D Culture Systems: Distribution by Sub-Type of Scaffold-Based System
Figure 6.3  3D Culture Systems: Distribution by Type of Hydrogels/ECMs
Figure 6.4  3D Culture Systems: Distribution of Solid Scaffolds
Figure 6.5  3D Culture Systems: Distribution by Sub-Type of Scaffold-Free Systems
Figure 6.6  3D Culture Systems: Distribution by Type of Suspension Cultures
Figure 6.7  3D Culture Systems: Distribution of Attachment Resistant Culture Surfaces
Figure 6.8  3D Culture System Manufacturers: Geographical Distribution of Developers
Figure 7.1  Cell-Mate3D: Cell Embedding Process
Figure 7.2  Types of Petaka Bioreactors Manufactured by Celartia
Figure 7.3  QGel Matrix: Key Features
Figure 7.4  QGel Bio: Validated Disease Models
Figure 7.5  RAFT Process Simulation
Figure 9.1  3D Culture: Effect on Stem Cell Differentiation
Figure 9.2 Methods for Embryoid Body Formation
Figure 9.3  AlphaMAX3D: Key Advantages
Figure 9.4  Lipidure-COAT Plates: Spheroid Formation
Figure 9.5 Lipidure-COAT Dishes: Diameter of Embryoid Bodies (in µm)
Figure 9.6 MaxGel Human ECM: Procedure for Thin Layer Coating
Figure 9.7  Perfecta3D Hanging Drop Culture Plates: Types of Co-Culture Spheroids
Figure 9.8  PGMatrix: Key Advantages
Figure 10.1  3D Culture Market Forecast, 2015 - 2025: Base Scenario (USD Million)
Figure 10.2  3D Culture Market Forecast, 2015-2025: Sub Market Evolution by Components (USD Million)
Figure 10.3  3D Culture Market Forecast, 2015-2025: Distribution by Components
Figure 10.4  3D Culture Market Forecast, 2015-2025: Geographical Analysis
Figure 10.5  3D Culture Market Forecast, 2015-2025: Distribution by Application
Figure 10.6  3D Culture Market Forecast, 2015-2025: Distribution by Type of 3D Culture System (USD Million)
Figure 11.1  Corning: Revenues by Business Divisions, 2014 (USD Billion)
Figure 11.2 Corning Life Sciences: Revenues 2011-2014 (USD Million)
Figure 11.3  Life Technologies: Revenues 2010-2013 (USD Billion)
Figure 11.4  Sigma-Aldrich: Revenues, 2010-2014 (USD Billion)
Figure 11.5  Cosmo Bio: Revenues, 2011 – 2014 (USD Million)
Figure 12.1 Cell Behaviour and Signalling: 2D versus 3D Cultures
Figure 12.2 3D Culture Market (USD Million), 2015, 2020 and 2025

List of Tables

Table 3.1  Morphology of Cells in a Culture
Table 4.1  Advantages and Disadvantages of Scaffold-Based and Scaffold-Free Systems
Table 4.2  Advantages and Disadvantages of Natural and Synthetic Scaffolds
Table 4.3  Advantages and Disadvantages of Natural and Synthetic Hydrogels
Table 4.4  Cell Cultures Used in Magnetic Levitation
Table 5.1  3D Culture Studies Using Porous Scaffolds
Table 5.2  Fabrication of Porous Scaffolds: Merits and Demerits
Table 5.3  3D Cell Culture Studies using Fibrous Scaffolds
Table 5.4  Fabrication of Fibrous Scaffolds: Merits and Demerits
Table 5.5  3D Cell Culture Studies Using Hydrogels
Table 5.6  Fabrication of Hydrogels: Merits and Demerits
Table 5.7  3D Culture Studies Using Custom Scaffolds
Table 5.8  Fabrication of Custom Scaffolds: Merits and Demerits
Table 5.9  3D Cell Culture Studies Using Microspheres
Table 5.10  Fabrication of Microspheres: Merits and Demerits
Table 5.11  3D Cell Culture Studies Using Native Scaffolds
Table 5.12  Fabrication of Native Scaffolds: Merits and Demerits
Table 6.1  3D Culture System Market Landscape
Table 6.2  3D Culture Market Landscape: Assay Kits, Reagents Suppliers
Table 6.3  3D Culture Market Landscape: Services
Table 7.1  Examples of 3D Culture Systems Used in Cancer Research
Table 7.2  Elplasia Micro-Space Cell Culture Plate: Specifications
Table 8.1  Examples of 3D Culture Systems Used in Drug and Toxicity Screening
Table 8.2  OrganoPlates: Specifications
Table 9.1  Example of 3D Culture Systems Used in Stem Cell Research
Table 9.2  Product Specification: CultrexBME
Table 11.1  Corning Life Science Product Specification: Matrigel Matrices
Table 11.2  Corning Life Science Product Specification: Collagen I
Table 11.3  Corning Life Sciences Product Specification: ULA Dishes
Table 11.4  Corning Life Science Product Specification: ULA Flasks
Table 11.5  Life Technologies Product Specification: AlgiMatrix
Table 11.6  Life Technologies Product Specification: Collagen I Proteins
Table 11.7  Sigma-Aldrich Product Specification: HydroMatrix Hydrogels
Table 11.8  Sigma-Aldrich Product Specification: MaxGel ECM
Table 11.9  InSphero Product Specification: 3D InSight Liver Microtissues
Table 11.10  InSphero Product Specification: 3D InSight Pancreatic Microtissues
Table 11.11  InSphero Product Specification: 3D InSight Tumour Microtissues
Table 11.12  3D Biotek: Product Dimensions
Table 11.13  3D Biotek Product Specification: 3D Insert-PS
Table 11.14  3D Biotek Product Specification: 3D Insert PCL
Table 11.15  Reinnervate Product Specification: Alvetex 3D Culture Scaffold
Table 11.16  Reinnervate: Collaborations
Table 11.17  Synthecon Product Specification: Rotary Cell Culture Systems
Table 11.18  Synthecon Product Specification: NanobioMatrix Scaffolds
Table 11.19  Synthecon Product Specification: Biostructure Matrix Scaffolds
Table 11.20  Neuromics Product Specification: CollaGel Hydrogels
Table 11.21  Neuromics Product Specification: 3D Nanofiber Solutions
Table 11.22  Neuromics Product Specification: AlphaGEL 3D
Table 11.23 Neuromics Product Specification :ECM Proteins
Table 11.24 Neuromics Product Specification: Petaka Culturing systems
Table 11.25  Cosmo Bio Product Specification: Mebiol Gel
Table 11.26  Cosmo Bio Product Specifications: Chitosan Coated Cultureware
Table 11.27  Cosmo Bio Product Specification: Alginate 3D Cell Culture Kit
Table 11.28  Cosmo Bio Product Specification: VECELL 3D Cell Culture Plates
Table 11.29  Cosmo Bio Product Specification: Atelocell
Table 11.30  Cosmo Bio Product Specification: LIPIDURE-COAT Cultureware
Table 14.1  3D Culture Systems: Distribution by Type of System
Table 14.2  3D Culture Systems: Distribution by Sub-Type of Scaffold-Based System
Table 14.3  3D Culture Systems: Distribution by Type of Hydrogels/ECMs
Table 14.4  3D Culture: Distribution of Solid Scaffolds
Table 14.5  3D Culture Systems: Distribution by Sub-Type of Scaffold-Free Systems
Table 14.6  3D Culture Systems: Distribution by Type of Suspension Cultures
Table 14.7  3D Culture: Distribution of Attachment Resistant Culture Surfaces
Table 14.8  3D Culture System Manufacturers: Geographical Distribution of Developers
Table 14.9  Lipidure-COAT Dishes: Diameter of Embryoid Bodies (in µm)
Table 14.10  3D Culture Market Forecast, 2015 - 2025: Base Scenario (USD Million)
Table 14.11  3D Culture Market Forecast, 2015 - 2025: Conservative Scenario (USD Million)
Table 14.12  3D Culture Market Forecast, 2015 - 2025: Optimistic Scenario (USD Million)
Table 14.13  3D Culture Market Forecast, 2015-2025: Sub Market Evolution by Components (USD Million)
Table 14.14 3D Culture Market Forecast, 2015-2025: Distribution by Components
Table 14.15 3D Culture Market Forecast, 2015-2025: Geographical Analysis
Table 14.16  3D Culture Market Forecast, 2015-2025: Distribution by Application
Table 14.17  3D Culture Market Forecast, 2015-2025: Distribution by Type of 3D System (USD Million)
Table 14.18  Corning: Revenues by Business Divisions, 2014 (USD Billion)
Table 14.19  Corning Life Sciences: Revenues 2011-14 (USD Million)
Table 14.20  Life Technologies: Revenues 2010-2013 (USD Billion)
Table 14.21  Sigma-Aldrich: Revenues, 2010-14 (USD Billion)
Table 14.22  Cosmo Bio: Revenues, 2011 – 2014 (USD Million)
Table 14.23  3D Culture Market (USD Million), 2015, 2020 and 2025

Listed Companies

The following companies and institutes have been mentioned in this report.

  1. 3D Biomatrix
  2. 3D Biotek, LLC
  3. 4titude
  4. Abbvie
  5. Agilent
  6. Akron Biotechnology, LLC
  7. Alphagenix
  8. AMS Bio
  9. AstraZeneca Pharmaceuticals
  10. Austrianova
  11. Avanticell Science
  12. BASF
  13. BD Bioscience
  14. BellBrook Labs
  15. Bethesda Research Laboratories
  16. Bio Connect
  17. Bio-Byblos Biomedical Co. Ltd.
  18. BioCellChallenge
  19. Biogelx Ltd.
  20. Biomerix
  21. Biozol GmbH
  22. BRTI Life Sciences
  23. Celartia
  24. Celenys SAS
  25. CellecBiotek AG
  26. Cellendes GmbH
  27. ChemieBrunschwig AG
  28. Cleveland Clinic
  29. Clontech
  30. CN Bio Innovations Ltd.
  31. Corning Life Sciences
  32. Cosmo Bio Co. Ltd.
  33. Cytoo
  34. Dexter Corporation
  35. Durham University
  36. EMD Millipore
  37. Emulate Inc.
  38. ESI Bio
  39. Euroclone
  40. European Union's Seventh Framework Programme (FP7) for Research and Technology Development
  41. Factors Technical University Dortmund
  42. FMC BioPolymer AS
  43. Fujifilm
  44. GE Healthcare
  45. GeneON GmbH
  46. Generon
  47. GIBCO Corporation
  48. GlaxoSmithKline
  49. Global Cell Solutions
  50. GlycosanBioSystems
  51. Greiner Bio-one
  52. Hµrel Corporation
  53. Hamilton Company
  54. Heidelberg University Hospital
  55. Hepregen Corp
  56. Hokkaido Soda
  57. In Vitro AS
  58. Insphero
  59. Instron
  60. Invivo Sciences
  61. Iris Biosciences
  62. Japan Vilene Company
  63. Karolinska Institute
  64. Kirkstall
  65. Kiyatec
  66. Koken Co. Ltd.
  67. Kolloidis Biosciences
  68. Kuraray Co., Ltd.
  69. Leibniz Research Centre For Working Environment and Human
  70. Lena Biosciences
  71. Life Technologies
  72. Lifecore Biomedical,
  73. Locate Therapeutics
  74. LuoLabs
  75. Massachusetts General Hospital
  76. MatTek Corporation
  77. MC2 Biotek
  78. Mebiol Inc.
  79. Medicyte
  80. Menicon Life Science
  81. Merck
  82. MicroTissues Inc.
  83. Mimetas B.V.
  84. Mirus Bio
  85. n3D Biosciences, Inc.
  86. Nanofiber Solutions
  87. NASA
  88. National Cancer Institute
  89. National Institute of Health
  90. National Institute of Standards and Technology
  91. NC3Rs
  92. Neuromics
  93. NOF Corporation
  94. Oncotest GmbH
  95. Organovo Holdings Inc.
  96. ParticipatiemaatschapijOost Nederland
  97. PepGel LLC
  98. Pfizer
  99. Prodizen
  100. Promega
  101. Protea Biosciences
  102. Protista International AB
  103. QGel Bio
  104. Radboudumc Pharmacology
  105. RealBio Technology Inc.
  106. Reinnervate
  107. Roche
  108. RoslinCellab
  109. Sanofi
  110. SBH Sciences
  111. Scivax Life Sciences
  112. Sigma Aldrich
  113. Solidus Biosciences, Inc.
  114. SoloHill
  115. Stemcell Technologies
  116. Sumitomo Bakelite Co. Ltd.
  117. Swiss Federal Institute of Technology
  118. Swiss FHNW
  119. Synthecon Incorporated
  120. SynVivo LLC
  121. TAP Biosystems
  122. Tecan
  123. Thermo Scientific
  124. Tianjin WeikaiBioeng Ltd.
  125. Trevigen
  126. Univalor
  127. University College London
  128. University of Illinois
  129. University of Liverpool
  130. University of Reading
  131. University of Utrecht
  132. University Zurich
  133. UPM
  134. VesselxIKKO-ZU
  135. VistaGen Therapeutics
  136. Vivo Biosciences
  137. WiCell Research Institute
  138. Wyss Institute, Harvard University
  139. ZeeuwsInvesteringsFonds
  140. Zyoxel


USD 2,199

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases